Back to Search Start Over

Infliximab as first-line therapy for severe Crohn's disease?

Authors :
Cohen RD
Source :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2002 Jan; Vol. 8 (1), pp. 58-9; discussion 63-5.
Publication Year :
2002

Subjects

Subjects :
Antibodies, Monoclonal adverse effects
Gastrointestinal Agents adverse effects
Humans
Infliximab
Severity of Illness Index
Antibodies, Monoclonal therapeutic use
Crohn Disease drug therapy
Gastrointestinal Agents therapeutic use

Details

Language :
English
ISSN :
1078-0998
Volume :
8
Issue :
1
Database :
MEDLINE
Journal :
Inflammatory bowel diseases
Publication Type :
Academic Journal
Accession number :
11837940
Full Text :
https://doi.org/10.1097/00054725-200201000-00010
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details